Moscow, Russia
Rapid Bio, LLC. is a Russian startup focused on the development of rapid diagnostics and healthcare solutions. The company was founded in 2020 and operates in the biotechnology and healthcare industries. Rapid Bio is positioned as a resident of the Skolkovo Innovation Center and is registered in the Republic of Buryatia, demonstrating its commitment to innovation. Known for its certified laboratory and production facilities located in the Skolkovo Technopark, the company complies with the ISO 13485 standard, ensuring high-quality outputs.
At the core of Rapid Bio's value proposition is its goal to create affordable and accurate rapid diagnostics for healthcare, a mission underscored by its team's expertise in biotechnology, development, and production of rapid tests. The company envisions shaping the future of healthcare through cutting-edge technologies, making it a potential player in the burgeoning diagnostics market.
While specific details regarding the startup's funding and investors are not publicly disclosed, the potential for Rapid Bio to revolutionize the diagnostic industry through its technological innovation is noteworthy. As an investor, monitoring its progress and potential funding rounds could present enticing investment opportunities in the burgeoning healthcare technology sector.
